Position in ARDX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,332,966
+$171,164 QoQ
Shares Held
222,532
+11.7% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Headlands Technologies LLC holds $47,716,225 across 76 Biotechnology names. ARDX ranks #10 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IBRX |
ImmunityBio, Inc.
|
397,170 | $3,046,293 | |
| 2 | NKTR |
Nektar Therapeutics
|
28,244 | $2,032,155 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
|
59,257 | $2,004,664 | |
| 4 | VERA |
Vera Therapeutics, Inc.
|
49,223 | $1,980,241 | |
| 5 | MLTX |
MoonLake Immunotherapeutics
|
97,133 | $1,810,559 | |
| 6 | GPCR |
Structure Therapeutics Inc.
|
37,156 | $1,790,919 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
49,146 | $1,599,210 | |
| 8 | NVAX |
Novavax Inc
|
189,675 | $1,543,954 |
All Filings in ARDX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,332,966 | 222,532 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,161,802 | 199,280 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $502,330 | 91,167 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | $108,329 | 22,063 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $11,944 | 2,356 | Shares | Sole | 2025-02-12 | |
| 2023-06-30 | $17,299 | 5,103 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $866 | 181 | Shares | Sole | 2023-05-01 | |
| No filing history on record for this holder in this stock. | ||||||